Kura Oncology (KURA) Change in Receivables (2014 - 2026)
Kura Oncology (KURA) reported Change in Receivables of $544000.0 for Q1 2026, down 98.83% year-over-year from $46.7 million in Q1 2025, and up 102.01% on a QoQ basis from -$27.1 million in Q4 2025.
Kura Oncology (KURA) has 9 years of Change in Receivables data on file, last reported at $544000.0 in Q1 2026.
- Quarterly Change in Receivables fell 98.83% year-over-year to $544000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39.4 million (down 184.53% YoY) and the FY2025 annual result came in at $6.7 million, up 227.38% from the prior year.
- Change in Receivables rose to $544000.0 in Q1 2026 per KURA's latest filing, from -$27.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $46.7 million in Q1 2025 and bottomed at -$44.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 544,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 544,000.00 |
| Mar 31, 2026 | 544,000.00 |
| Dec 31, 2025 | -27.13 Mn |
| Dec 31, 2025 | -27.13 Mn |
| Sep 30, 2025 | 31.36 Mn |
| Sep 30, 2025 | 31.36 Mn |
| Jun 30, 2025 | -44.17 Mn |
| Jun 30, 2025 | -44.17 Mn |
| Mar 31, 2025 | 46.69 Mn |
| Mar 31, 2025 | 46.69 Mn |
| Mar 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | -17,000.00 |
| Dec 31, 2019 | -17,000.00 |
| Sep 30, 2019 | -64,000.00 |
| Sep 30, 2019 | -64,000.00 |
| Jun 30, 2019 | -84,000.00 |
| Jun 30, 2019 | -84,000.00 |
| Mar 31, 2019 | -45,000.00 |
| Mar 31, 2019 | -45,000.00 |
| Dec 31, 2018 | -8,000.00 |
| Dec 31, 2018 | -8,000.00 |
| Sep 30, 2018 | 2,000.00 |
| Sep 30, 2018 | 2,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Jun 30, 2018 | -27,000.00 |
| Mar 31, 2018 | 41,000.00 |
| Mar 31, 2018 | 41,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Dec 31, 2017 | 7,000.00 |
| Sep 30, 2017 | -95,000.00 |
| Sep 30, 2017 | -95,000.00 |
| Jun 30, 2017 | -37,000.00 |
| Jun 30, 2017 | -37,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Mar 31, 2017 | 46,000.00 |
| Dec 31, 2016 | 34,000.00 |
| Dec 31, 2016 | 34,000.00 |
| Sep 30, 2016 | -25,000.00 |
| Sep 30, 2016 | -25,000.00 |
| Jun 30, 2016 | -120,000.00 |
| Jun 30, 2016 | -120,000.00 |
| Mar 31, 2016 | -24,000.00 |
| Mar 31, 2016 | -24,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Dec 31, 2015 | 51,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Jun 30, 2015 | 24,000.00 |
| Jun 30, 2015 | 24,000.00 |
| Mar 31, 2015 | 318,000.00 |
| Mar 31, 2015 | 318,000.00 |
| Dec 31, 2014 | 30,000.00 |
| Dec 31, 2014 | 30,000.00 |